Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current topics in mycology].

M Khan1, M Plempel, S W Wassilew

  • 1Dermatologische Klinik der Städt. Krankenanstalten, Krefeld.

Zeitschrift Fur Hautkrankheiten
|October 15, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OCULAR MANIFESTATIONS IN A PATIENT WITH HIDRADENITIS SUPPURATIVA: A CASE STUDY.

Georgian medical news·2025
Same author

In the Nexus of Transformation: Innovations, Challenges and the Future of Digital Oncology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh.

Virology journal·2024
Same author

X-ray phase-contrast imaging of strong shocks on OMEGA EP.

The Review of scientific instruments·2024
Same author

A Rare Case of Partially Ossified Sacrospinous Ligament Causing Sciatic Nerve Compression.

Mymensingh medical journal : MMJ·2024
Same author

Immediate versus expedient emergent laparotomy in unstable isolated abdominal trauma patients.

Annals of the Royal College of Surgeons of England·2024
Same journal

[Acne vulgaris: morphologic, endocrinologic and psychosomatic aspects].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Anti-androgen treatment of hirsutism with cyproterone acetate].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Changes in sunscreening products in West Germany between 1988 and 1989/90].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Effect of treatment with salt from the Dead Sea (Tomesa therapy) on epidermal Langerhans cells--a clinical study].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[DNA determination by cytophotometry in bowenoid papules in comparison with condylomata acuminata and Bowen's disease].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Adverse drug reactions on hair].

Zeitschrift fur Hautkrankheiten·1990
See all related articles

Developing reliable in vitro antifungal susceptibility testing is crucial for discovering new, affordable antimycotics and guiding yeast infection treatments. Current agar dilution methods for measuring minimal inhibitory concentration (MIC) show variability due to technical factors.

Area of Science:

  • Mycology
  • Microbiology
  • Pharmacology

Context:

  • Antimycotic therapy requires accurate susceptibility testing for yeasts.
  • In vitro methods with high in vivo predictability are needed for new drug discovery.
  • Current agar dilution methods for minimal inhibitory concentration (MIC) determination present challenges.

Purpose:

  • To highlight the limitations of current agar dilution methods for yeast susceptibility testing.
  • To emphasize the need for improved in vitro methods for antimycotic development and therapy.
  • To discuss factors influencing MIC variability in azole antifungal susceptibility testing.

Summary:

  • Agar dilution methods for determining the minimal inhibitory concentration (MIC) of antifungals against yeasts are influenced by multiple factors, including inoculum size, incubation time, and culture medium.

Related Experiment Videos

  • This variability affects the reliability of MIC values for azoles, impacting both the discovery of new antimycotics and the clinical management of yeast infections.
  • Existing in vitro methods do not adequately account for the diverse growth characteristics of fungi in vitro and in vivo.

    • Impact:

    • Improved in vitro testing will facilitate the development of more affordable and effective antimycotic drugs.
    • Enhanced susceptibility testing will lead to more personalized and successful antifungal therapies.
    • Addressing the limitations of current methods is essential for advancing the field of antifungal drug discovery and clinical application.